Location History:
- Nova Scotia, CA (2002)
- Halifax, CA (2014 - 2020)
Company Filing History:
Years Active: 2002-2020
Title: Innovations of Christopher McMaster
Introduction
Christopher McMaster is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of medical research, particularly in the treatment of retinal diseases. With a total of five patents to his name, McMaster's work focuses on innovative therapeutic methods.
Latest Patents
Among his latest patents, McMaster has developed S1PR2 antagonists and their applications for treating familial exudative vitreoretinopathy (FEVR). These methods and compositions involve administering a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Additionally, he has worked on compounds such as (Z)-2-cyano-1-(2,6-dichloropyridin-4-yl)-3-((4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)methyl)guanidine and its analogs, which are used in treating retinopathies and diseases characterized by insufficient angiogenesis. Another patent includes (Z)-3-((2,6-dichloropyridin-4-yl)amino)-3-(((4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)methyl)amino)acrylonitrile and its analogs, further contributing to advancements in this medical field.
Career Highlights
Christopher McMaster has had a distinguished career, working at Dalhousie University, where he has been involved in various research projects. His expertise in pharmacology and innovative approaches to treatment have positioned him as a key figure in his field.
Collaborations
Throughout his career, McMaster has collaborated with notable colleagues, including Gordon Simms and Fan Wu. These partnerships have enhanced his research and contributed to the development of his patented inventions.
Conclusion
Christopher McMaster's innovative work in the field of medical research, particularly in the treatment of retinal diseases, showcases his dedication to improving patient outcomes. His contributions through patents and collaborations highlight the importance of innovation in healthcare.